Commonly reported side effects of sunitinib include: oral candidiasis, asthenia, decreased left ventricular ejection fraction, diarrhea, hypokalemia, lymphocytopenia, mucositis, neutropenia, vomiting, and hypertension. Other side effects include: severe hypertension.  See below for a comprehensive list of adverse effects.
As well as its needed effects, sunitinib may cause unwanted side effects that require medical attention. 
If any of the following side effects occur while taking sunitinib, check with your doctor immediately:
Some sunitinib side effects may not need any medical attention. As your body gets used to the medicine these side effects may disappear. Your health care professional may be able to help you prevent or reduce these side effects, but do check with them if any of the following side effects continue, or if you are concerned about them:
The most common side effects included fatigue, asthenia, fever, diarrhea, nausea, mucositis/stomatitis, vomiting, dyspepsia, abdominal pain, constipation, hypertension, peripheral edema, rash, hand and foot syndrome, skin discoloration, dry skin, hair color changes, altered taste, headache, back pain, arthralgia, extremity pain, cough, dyspnea, anorexia, and bleeding.  The most serious adverse reactions included hepatotoxicity, renal failure, heart failure, pulmonary embolism, gastrointestinal perforation, and hemorrhages.
Very common (10% or more): Diarrhea (up to 66%), nausea (up to 58%), mucositis/stomatitis (up to 49%), abdominal pain (up to 44%), vomiting (up to 39%), dyspepsia (up to 34%), constipation (up to 28%), dry mouth (up to 13%), flatulence (up to 15%), oral pain (up to 14%), GERD/reflux esophagitis (up to 12%), glossodynia (up to 11%), laboratory abnormalities including lipase elevations (up to 56%), amylase elevations (up to 35%) Common (1% to 10%): Hemorrhoids, dysphagia, esophagitis, abdominal discomfort, rectal hemorrhage, gingival bleeding, mouth ulceration, proctalgia, cheilitis, oral discomfort, eructation Uncommon (0.1% to 1%): Pancreatitis, intestinal perforation, anal fistulaPostmarketing reports: Esophagitis
Very common (10% or more): Neutropenia (18.3%), anemia (22%), thrombocytopenia (16.6%), bleeding events (18% to 37%), laboratory abnormalities including decreases in neutrophils (up to 77%), lymphocytes (up to 68%), leukocytes ( up to 78%), platelets (up to 68%), and hemoglobin (up to 79%)Common (1% to 10%): Leukopenia, lymphopeniaUncommon (0.1% to 1%): PancytopeniaPostmarketing reports: Thrombotic microangiopathy
Postmarketing bleeding events have included gastrointestinal, respiratory, tumor, urinary tract, and brain hemorrhages, some of which have been fatal.  During clinical trials, bleeding events were reported in 37% (140 of 375) of patients with renal cell carcinoma (RCC) receiving sunitinib compared with 10% receiving interferon alpha.  In the gastrointestinal stromal tumor (GIST) study, bleeding events were reported in 18% (37 of 202) of the sunitinib-treated patients compared with 17% (17 of 102) in placebo.  Epistaxis was commonly reported; less frequent reports included rectal, gingival, upper gastrointestinal, genital, and wound bleeding.
Very common (10% or more): Altered taste (21% to 47%), headache (13% to 26%), dizziness (up to 13.6%)Common (1% to 10%): Peripheral neuropathy, paresthesia, hypoesthesia, hyperesthesiaUncommon (0.1% to 1%): Reversible posterior leukoencephalopathy syndrome, cerebrovascular accident, transient ischemic attackPostmarketing reports: Seizures
Very common (10% or more): Laboratory abnormalities including elevations of ALT (up to 72%), AST (up to 61%), alkaline phosphatase (up to 63%), total bilirubin (up to 37%), and indirect bilirubin (up to 13%) Uncommon (0.1% to 1%): Liver failure, cholecystitis , hepatitis, abnormal hepatic functionPostmarketing reports: Emphysematous cholecystitis, acalculous cholecystitis
Uncommon (0.1% to 1%): HypersensitivityPostmarketing reports: Hypersensitivity reactions, including angioedema
Very common (10% or more): Skin discoloration (up to 30%), rash (up to 30%), hand-foot syndrome (14% to 29%), hair color changes (up to 29%), dry skin (15% to 23%), alopecia (up to 14%), erythema (14%), pruritus (14%)Common (1% to 10%): Skin exfoliation, skin reaction, eczema, blister, acne, pruritus, hyperkeratosis, dermatitis, nail disorderUncommon (0.1% to 1%): Stevens-Johnson syndrome, toxic epidermal necrolysisFrequency not reported: Erythema multiforme, necrotizing fasciitisPostmarketing reports: Pyoderma gangrenosum
Very common (10% or more): Hypertension (up to 34%), peripheral edema (up to 24%), chest pain (13%), laboratory finding of decreased left ventricular ejection fraction (up to 16%)Common (1% to 10%): Venous thromboembolic events including deep vein thrombosis and pulmonary embolism, hot flush/flushingUncommon (0.1% to 1%): Congestive cardiac failure, cardiac failure, cardiomyopathy, pericardial effusion, left ventricular failureRare (less than 0.1%): Torsades de pointesPostmarketing reports: Arterial thromboembolic events including cerebrovascular accident, transient ischemic attack, and cerebral infarction.
Very common (10% or more): Myalgia/limb pain (11% to 40%), back pain (24% to 28%), arthralgia (19% to 23%), creatine kinase elevation (up to 49%)Common (1% to 10%): Muscle spasms, muscular weaknessUncommon (0.1% to 1%): Osteonecrosis of the jaw, fistulaPostmarketing reports: Fistula formation, myopathy and/or rhabdomyolysis
Very common (10% or more): Epistaxis (21%), cough (27%), dyspnea (16% to 26%), nasopharyngitis (14%), oropharyngeal pain (14%), upper respiratory infection (11%)Common (1% to 10%): Pulmonary embolism, pleural effusion, hemoptysis, nasal congestion, nasal drynessUncommon (0.1% to 1%): Pulmonary hemorrhage, respiratory failurePostmarketing reports: Pulmonary embolism
Very common (10% or more): Increased serum creatinine (up to 70%), Rare (less than 0.1%): Nephrotic syndromeFrequency not reported: Proteinuria Postmarketing reports: Renal impairment and/or failure
Very common (10% or more): Anorexia (up to 48%), weight loss (up to 16%), laboratory abnormalities including decreased potassium (up to 21% ), increased potassium (up to 18%), decreased calcium (up to 42%), increased calcium (13%), increased uric acid (up to 46%), increased glucose (up to 71%), decreased glucose (up to 22%), decreased sodium (up to 29%), increased sodium (up to 13%), decreased phosphorus (up to 36%), decreased magnesium (19% ), decreased albumin (up to 41%) Common (1% to 10%): Dehydration Uncommon (0.1% to 1%): Tumor lysis syndrome
Very common (10% or more): Fatigue (33% to 76%), asthenia (16% to 34%), fever (up to 22%), chills (up to 14%)Common (1% to 10%): Pain, influenza like symptoms Uncommon (0.1% to 1%): Impaired wound healing
Common (1% to 10%): Periorbital edema, eyelid edema, increased lacrimation
Very common (10% or more): Hypothyroidism (16%) Uncommon (0.1% to 1%): Hyperthyroidism
Very common (10% or more): Insomnia (15% to 18%), depression (up to 11%)
It is possible that some side effects of sunitinib may not have been reported. These can be reported to the FDA here. Always consult a healthcare professional for medical advice.
Bleeding gums
bloating or swelling of the face, arms, hands, fingers, lower legs, or feet
blurred vision
chest pain
chills
confusion
coughing up blood
cracked lips
decreased urination
decreased urine output
diarrhea
difficulty with breathing or swallowing
dilated neck veins
dizziness
dry mouth
extreme fatigue
fainting
fast, slow, or irregular heartbeat
fever
headache
increased menstrual flow or vaginal bleeding
irregular breathing
labored breathing
lightheadedness
nervousness
nosebleeds
paralysis
pounding in the ears
prolonged bleeding from cuts
rapid breathing
rapid weight gain
red or black, tarry stools
red or dark brown urine
sores, ulcers, or white spots on the lips, tongue, or inside the mouth
sunken eyes
swelling or inflammation of the mouth
thirst
tightness in the chest
tingling of the hands or feet
troubled breathing
unusual tiredness or weakness
unusual weight gain or loss
wrinkled skin
yellow eyes or skin
Bleeding from the rectum
bleeding from wounds
constipation
depressed mood
dry skin and hair
feeling cold
hair loss
hoarseness or husky voice
indigestion
loss of appetite
muscle cramps and stiffness
nausea
pain in the chest, groin, or legs, especially the calves
pain in the stomach, side, or abdomen, possibly radiating to the back
severe stomach pain
severe, sudden headache
slurred speech
sudden loss of coordination
sudden, severe weakness or numbness in the arm or leg
vision changes
vomiting
vomiting of blood or material that looks like coffee grounds
Back pain
chest discomfort
cloudy or bloody urine
convulsions
darkening of the skin
drowsiness
general feeling of tiredness or weakness
irregular or slow heart rate
light-colored stools
mental depression
skin rash
stomach pain, continuing
Blistering, peeling, or loosening of the skin
cloudy urine
cough
coughing up blood
dark-colored urine
heavy jaw feeling
increased thirst
itching
joint pain, stiffness, or swelling
loosening of a tooth
lower back or side pain
muscle cramps or spasms
muscular pain, tenderness, wasting, or weakness
pain, swelling, or numbness in the mouth or jaw
painful or difficult urination
pale skin
red skin lesions, often with a purple center
sore throat
sudden, severe chest pain
unusual bleeding or bruising
weight gain
Acid or sour stomach
belching
blistering, peeling, redness, or swelling of the palms, hands, or bottoms of the feet
change in color of the treated skin
change in taste
difficulty with moving
discouragement
excess air or gas in the stomach or intestines
feeling sad or empty
full feeling
hair color changes
hair loss or thinning of the hair
heartburn
irritability
lack of appetite
lack or loss of strength
loss of interest or pleasure
muscle aches or pains
numbness, pain, tingling, or unusual sensations in the palms of the hands or bottoms of the feet
pain or burning in the throat
passing gas
stomach discomfort, upset, or pain
swollen joints
trouble concentrating
trouble sleeping